Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.36 USD | -1.69% | +5.56% | -13.43% |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 406M | Capitalization | 1.22B |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.55 x |
Net cash position 2024 * | 93.72M | Net cash position 2025 * | 88.72M | EV / Sales 2025 * | 2.78 x |
P/E ratio 2024 * |
-19.4
x | P/E ratio 2025 * |
494
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | +1.74% | ||
1 week | +4.16% | ||
Current month | +7.32% | ||
1 month | -0.19% | ||
3 months | -10.08% | ||
6 months | -18.64% | ||
Current year | -12.64% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +7.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 25.49 | -1.16% | 13 618 |
24-06-04 | 25.79 | +1.74% | 793,904 |
24-06-03 | 25.35 | +5.49% | 1,123,864 |
24-05-31 | 24.03 | -1.68% | 565,910 |
24-05-30 | 24.44 | +0.95% | 465,035 |
Delayed Quote Nasdaq, June 04, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.64% | 1.22B | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+40.06% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- MIRM Stock